Transcriptional_JJ
regulation_NN
of_IN
T_NN
lymphocyte_NN
development_NN
and_CC
function_NN
._.

The_DT
development_NN
and_CC
function_NN
of_IN
T_NN
lymphocytes_NNS
are_VBP
regulated_VBN
tightly_RB
by_IN
signal_NN
transduction_NN
pathways_NNS
that_WDT
include_VBP
specific_JJ
cell-surface_JJ
receptors_NNS
,_,
intracellular_JJ
signaling_NN
molecules_NNS
,_,
and_CC
nuclear_JJ
transcription_NN
factors_NNS
._.

Since_IN
1988_CD
,_,
several_JJ
families_NNS
of_IN
functionally_RB
important_JJ
T_NN
cell_NN
transcription_NN
factors_NNS
have_VBP
been_VBN
identified_VBN
._.

These_DT
include_VBP
the_DT
Ikaros_NN
,_,
LKLF_NN
,_,
and_CC
GATA3_NN
zinc-finger_NN
proteins_NNS
;_:
the_DT
Ets_NN
,_,
CREB\/ATF_NN
,_,
and_CC
NF-kappa_NN
B\/Rel\/NFAT_NN
transcription_NN
factors_NNS
;_:
the_DT
Stat_NN
proteins_NNS
;_:
and_CC
HMG_NN
box_NN
transcription_NN
factors_NNS
such_JJ
as_IN
LEF1_NN
,_,
TCF1_NN
,_,
and_CC
Sox4_NN
._.

In_IN
this_DT
review_NN
,_,
we_PRP
summarize_VBP
our_PRP$
current_JJ
understanding_NN
of_IN
the_DT
transcriptional_JJ
regulation_NN
of_IN
T_NN
cell_NN
development_NN
and_CC
function_NN
with_IN
particular_JJ
emphasis_NN
on_IN
the_DT
results_NNS
of_IN
recent_JJ
gene_NN
targeting_NN
and_CC
transgenic_JJ
experiments_NNS
._.

In_IN
addition_NN
to_TO
increasing_VBG
our_PRP$
understanding_NN
of_IN
the_DT
molecular_JJ
pathways_NNS
that_WDT
regulate_VBP
T_NN
cell_NN
development_NN
and_CC
function_NN
,_,
these_DT
results_NNS
have_VBP
suggested_VBN
novel_JJ
targets_NNS
for_IN
genetic_JJ
and_CC
pharmacological_JJ
manipulation_NN
of_IN
T_NN
cell_NN
immunity_NN
._.

